diclofenac has been researched along with ketorolac tromethamine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cabrita, EJ; Corvo, MC; Manso, J; Marques, MM; Viegas, A | 1 |
| Corli, O; De Conno, F; Gallucci, M; Piva, L; Speranza, R; Tamburini, M; Toscani, F; Ventafridda, V | 1 |
| Kamath, BV; Shah, AC; Shivram, K | 1 |
| Garbus, JJ; LaBree, LD; McDonnell, PJ; Seitz, B; Sorken, K | 1 |
| Abelson, MB; Betts, JG; Gill, D; Koester, JM; Laibovitz, RA; Ostrov, CS; Raizman, MB; Schaich, L; Tauber, J | 1 |
| Chuang, AZ; el-Harazi, SM; Feldman, RM; Ruiz, RS; Villanueva, G | 1 |
| Araullo-Cruz, T; Gordon, YJ; Romanowski, EG | 1 |
| Dolan, BJ; Donahue, ME; Faktorovich, EG; Flach, AJ; Gonzalez, GA | 1 |
| Bourque, LB; Brint, SF; Caplan, DI; McDonald, MB; Shoaf, K | 1 |
| Flach, A | 1 |
| Gordon, YJ; Romanowski, EG | 1 |
| Guidera, AC; Luchs, JI; Udell, IJ | 1 |
| Alexander, R; El-Moalem, HE; Gan, TJ | 1 |
| Rho, DS | 1 |
| Flach, AJ; Waterbury, LD | 1 |
| Kulkarni, SK; Naidu, PS; Padi, SS | 1 |
| Erdahl, WE; Gadd, ME; Graff, G; Kumar, J; Lal, N; Pfeiffer, DR; Yanni, JM | 1 |
| Acar, MA; Basci, N; Demir, NM; Demircan, S; Duman, S; Hazirolan, D; Kocaoglan, H; Sayin, F; Unlu, N | 1 |
| Domszy, R; Hu, N; Tammareddy, T; Torres-Luna, C; Wang, NS; Yang, A; Yang, J | 1 |
| Meekins, JM; Rankin, AJ; Roberts, JK; Roush, JK | 1 |
10 trial(s) available for diclofenac and ketorolac tromethamine
| Article | Year |
|---|---|
Ketorolac versus diclofenac sodium in cancer pain.
Topics: Adolescent; Adult; Aged; Analgesics; Diclofenac; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Neoplasms; Pain, Intractable; Single-Blind Method; Tolmetin; Tromethamine | 1994 |
Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Burns, Chemical; Cornea; Diclofenac; Double-Blind Method; Eye Burns; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Sensation; Tolmetin | 1996 |
A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Diclofenac; Double-Blind Method; Eye; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Seasons; Tolmetin | 1998 |
A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Count; Diclofenac; Double-Blind Method; Female; Humans; Intraocular Pressure; Ketorolac Tromethamine; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prednisolone; Safety; Tolmetin; Tromethamine; Uveitis, Anterior | 1998 |
Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Inflammation; Ketorolac Tromethamine; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Safety; Tolmetin; Treatment Outcome; Tromethamine; Uveitis, Anterior | 1998 |
Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Keratotomy, Radial; Ketorolac Tromethamine; Male; Middle Aged; Myopia; Ophthalmic Solutions; Pain, Postoperative; Prospective Studies; Surveys and Questionnaires; Tolmetin; Tromethamine; Visual Acuity | 1999 |
Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Hip Injuries; Humans; Ketorolac Tromethamine; Knee Injuries; Male; Middle Aged; Morphine; Pain; Pain Measurement; Time Factors | 2002 |
Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
Topics: Administration, Topical; Aged; Cyclooxygenase Inhibitors; Diclofenac; Drug Evaluation; Female; Humans; Ketorolac Tromethamine; Lens Implantation, Intraocular; Macular Edema; Male; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Pseudophakia; Treatment Outcome; Visual Acuity | 2003 |
Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial.
Topics: Administration, Topical; Adult; Aged; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Diclofenac; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Prospective Studies; Retinal Detachment; Scleral Buckling; Subretinal Fluid | 2010 |
Effects of topical instillation of 0.1% diclofenac sodium, 0.5% ketorolac tromethamine, and 0.03% flurbiprofen sodium on corneal sensitivity in ophthalmologically normal cats.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cats; Diclofenac; Flurbiprofen; Ketorolac Tromethamine; Ophthalmic Solutions | 2021 |
12 other study(ies) available for diclofenac and ketorolac tromethamine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.
Topics: Animals; Binding, Competitive; Catalytic Domain; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Female; Ibuprofen; Ketorolac; Magnetic Resonance Spectroscopy; Male; Sheep | 2011 |
Determination of diclofenac sodium, famotidine and ketorolac tromethamine by flow injection analysis using dichloronitrophenol.
Topics: Cyclooxygenase Inhibitors; Diclofenac; Drug Combinations; Famotidine; Flow Injection Analysis; Ketorolac Tromethamine; Methanol; Nitrophenols; Tolmetin; Tromethamine | 1994 |
The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
Topics: Adenoviridae; Adenoviridae Infections; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Eye Infections, Viral; Female; Glucocorticoids; Keratoconjunctivitis; Ketorolac Tromethamine; Ophthalmic Solutions; Prednisolone; Rabbits; Tolmetin; Tromethamine; Virus Replication | 1998 |
Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Cornea; Corneal Diseases; Diclofenac; Health Surveys; Humans; Ketorolac Tromethamine; Ophthalmic Solutions; Product Surveillance, Postmarketing; Safety | 2000 |
Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cidofovir; Corneal Stroma; Cytosine; Diclofenac; Drug Interactions; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Keratitis; Ketorolac Tromethamine; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Random Allocation; Virus Replication; Virus Shedding | 2001 |
Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Corneal Ulcer; Diclofenac; Female; Humans; Keratitis; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Rupture | 2001 |
Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammation.
Topics: Androstadienes; Animals; Anti-Inflammatory Agents; Diclofenac; Disease Models, Animal; Endophthalmitis; Ketorolac Tromethamine; Loteprednol Etabonate; Rabbits | 2006 |
Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac; Dose-Response Relationship, Drug; Facial Pain; Injections, Intraperitoneal; Injections, Subcutaneous; Ketorolac Tromethamine; Male; Pain Measurement; Prostaglandins; Rats; Rats, Wistar; Time Factors | 2006 |
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Celecoxib; Diclofenac; Ketorolac Tromethamine; Male; Membrane Potentials; Mitochondria, Liver; Molecular Structure; Oxidative Stress; Permeability; Phenylacetates; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature; Time Factors | 2009 |
Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contact Lenses, Hydrophilic; Delayed-Action Preparations; Diclofenac; Drug Delivery Systems; Fatty Alcohols; Flurbiprofen; Ketorolac Tromethamine; Quaternary Ammonium Compounds; Surface-Active Agents; Vitamin E | 2019 |